These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9180382)

  • 1. The rational construction of an antibody against cystatin: lessons from the crystal structure of an artificial Fab fragment.
    Schiweck W; Skerra A
    J Mol Biol; 1997 May; 268(5):934-51. PubMed ID: 9180382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The de novo design of an antibody combining site. Crystallographic analysis of the VL domain confirms the structural model.
    Essen LO; Skerra A
    J Mol Biol; 1994 Apr; 238(2):226-44. PubMed ID: 8158652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fermenter production of an artificial fab fragment, rationally designed for the antigen cystatin, and its optimized crystallization through constant domain shuffling.
    Schiweck W; Skerra A
    Proteins; 1995 Dec; 23(4):561-5. PubMed ID: 8749852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
    Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
    J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of an antigen-binding fragment bound to single-stranded DNA.
    Tanner JJ; Komissarov AA; Deutscher SL
    J Mol Biol; 2001 Dec; 314(4):807-22. PubMed ID: 11733999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
    Clark LA; Boriack-Sjodin PA; Day E; Eldredge J; Fitch C; Jarpe M; Miller S; Li Y; Simon K; van Vlijmen HW
    Protein Eng Des Sel; 2009 Feb; 22(2):93-101. PubMed ID: 19074157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
    Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
    J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen.
    Li Y; Urrutia M; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 2003 Jan; 42(1):11-22. PubMed ID: 12515535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local and transmitted conformational changes on complexation of an anti-sweetener Fab.
    Guddat LW; Shan L; Anchin JM; Linthicum DS; Edmundson AB
    J Mol Biol; 1994 Feb; 236(1):247-74. PubMed ID: 7893280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional structure of an Fab-peptide complex: structural basis of HIV-1 protease inhibition by a monoclonal antibody.
    Lescar J; Stouracova R; Riottot MM; Chitarra V; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
    J Mol Biol; 1997 Apr; 267(5):1207-22. PubMed ID: 9150407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2.5 A resolution structure of the jel42 Fab fragment/HPr complex.
    Prasad L; Waygood EB; Lee JS; Delbaere LT
    J Mol Biol; 1998 Jul; 280(5):829-45. PubMed ID: 9671553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of human immunoglobulin fragment Fab New refined at 2.0 A resolution.
    Saul FA; Poljak RJ
    Proteins; 1992 Nov; 14(3):363-71. PubMed ID: 1438175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
    Boehm MK; Woof JM; Kerr MA; Perkins SJ
    J Mol Biol; 1999 Mar; 286(5):1421-47. PubMed ID: 10064707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed analysis of the free and bound conformations of an antibody. X-ray structures of Fab 17/9 and three different Fab-peptide complexes.
    Schulze-Gahmen U; Rini JM; Wilson IA
    J Mol Biol; 1993 Dec; 234(4):1098-118. PubMed ID: 8263915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization and crystallization of an antibody Fab fragment that recognizes RNA. Crystal structures of native Fab and three Fab-mononucleotide complexes.
    Pokkuluri PR; Bouthillier F; Li Y; Kuderova A; Lee J; Cygler M
    J Mol Biol; 1994 Oct; 243(2):283-97. PubMed ID: 7523684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural consequences of humanizing an antibody.
    Holmes MA; Foote J
    J Immunol; 1997 Mar; 158(5):2192-201. PubMed ID: 9036965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the disulfide-stabilized Fv fragment of anticancer antibody B1: conformational influence of an engineered disulfide bond.
    Almog O; Benhar I; Vasmatzis G; Tordova M; Lee B; Pastan I; Gilliland GL
    Proteins; 1998 May; 31(2):128-38. PubMed ID: 9593187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystallographic analysis of the NNA7 Fab and proposal for the mode of human blood-group recognition.
    Xie K; Song SC; Spitalnik SL; Wedekind JE
    Acta Crystallogr D Biol Crystallogr; 2005 Oct; 61(Pt 10):1386-94. PubMed ID: 16204891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
    Covaceuszach S; Cattaneo A; Lamba D
    Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.